ExCulture is developing an animal-free alternative to heparin using bio-based secondary feedstocks
ExCulture is developing an animal-free alternative to heparin using bio-based secondary feedstocks. The company focuses on processing biowaste-derived material into complex biopharmaceutical compounds, with heparin as their showcase product.